EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring Risks of Adverse Drug Events From Single Drug to Three‐Drug Combination

Yi Shi iD, Anna Sun iD, Chien-Wei Chiang, Yuedi Yang iD, Katherine M Hunold iD, Jing Xu iD, Mu Shan, Allison Lu, Massimiliano Russo, Jeffrey M Caterino, Michael T Eadon iD, Lang Li und 3 weitere

Clinical and Translational Science · 2026-08 · 19 (8)

DOI: 10.1111/cts.70672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 18.07.2026. Verfasst von Yi Shi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Acute Kidney Injury, Gastrointestinal Hemorrhage. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Use of three‐drug combinations is common and could increase the risk of adverse drug events (ADEs). Signals of ADEs from three‐drug combinations could be identified from real‐world data, and the risks of ADEs from single drug exposure to three‐drug combination exposure could be illustrated by a graphic model. We used a US nationwide insurance claim database. We explored the relationship between drug exposure (from single drugs to three‐drug combinations) and risks of ADEs (acute kidney injury, gastrointestinal bleeding, and opioid‐related ADE). We used a conditional logistic regression model to estimate the odds ratios (ORs), the posterior probability of null hypothesis to control false discovery rate (FDR), and a graphic model to illustrate the ORs from single drug exposure to three‐drug combination exposure. We derived approximately 1.7 million covariate‐matched ADE‐case–control pairs and investigated approximately 0.25 million three‐drug combinations. We identified 3412 signals of adverse three‐drug combinations (FDR < 0.01 and OR > 2). For the signals, we observed the medians and interquartile ranges (IQRs) of ORs increased from single drug exposure (median = 1.03, IQR: 0.95–1.15), through two‐drug combination exposure (median = 1.45, IQR: 1.23–1.75), to three‐drug combination exposure (median = 2.95, IQR: 2.43–3.91). We built a webpage‐based tool to illustrate the ORs from single drug exposure to three‐drug combination exposure. In conclusion, certain three‐drug combinations are associated with an increased risk of ADE, and the risks of ADE could increase from single drug exposure to three‐drug combination exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsAcute Kidney InjuryGastrointestinal HemorrhageHumansDatabases, FactualDrug CombinationsOdds RatioUnited StatesRisk AssessmentRisk FactorsDrug InteractionsAnalgesics, OpioidCase-Control StudiesLogistic Models

Stichwörter der Autor:innen

acute kidney injuryadverse drug event (ADE)drug interactiongastrointestinal bleedingopioidthree‐drug combination

Substanzen

Drug CombinationsAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA.
  • Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA.
  • Department of Emergency Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Department of Computer Science, Purdue University, West Lafayette, Indiana, USA.
  • Department of Statistics, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Yi Shi, Anna Sun, Yuedi Yang, Katherine M Hunold, Jing Xu, Michael T Eadon, Jing Su, Macarius Donneyong, Pengyue Zhang

Zitieren

APA

Shi, Y., Sun, A., Chiang, C. W., Yang, Y., Hunold, K. M., Xu, J., Shan, M., Lu, A., Russo, M., Caterino, J. M., Eadon, M. T., Li, L., Su, J., Donneyong, M., & Zhang, P. (2026). Exploring Risks of Adverse Drug Events From Single Drug to Three‐Drug Combination. Clinical and Translational Science, 19(8). https://doi.org/10.1111/cts.70672

Vancouver

Shi Y, Sun A, Chiang CW, Yang Y, Hunold KM, Xu J, et al. Exploring Risks of Adverse Drug Events From Single Drug to Three‐Drug Combination. Clinical and Translational Science. 2026;19(8). doi:10.1111/cts.70672

BibTeX
@article{Shi2026,
  author = {Shi, Yi and Sun, Anna and Chiang, Chien-Wei and Yang, Yuedi and Hunold, Katherine M and Xu, Jing and Shan, Mu and Lu, Allison and Russo, Massimiliano and Caterino, Jeffrey M and Eadon, Michael T and Li, Lang and Su, Jing and Donneyong, Macarius and Zhang, Pengyue},
  title = {Exploring Risks of Adverse Drug Events From Single Drug to Three‐Drug Combination},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {8},
  doi = {10.1111/cts.70672}
}
Kostenlos starten →